Avaleht › 2. tüüpi diabeet › Alabama
2. tüüpi diabeet kliinilised uuringud osariigis Alabama
22 uuringut haiguse 2. tüüpi diabeet jaoks otsivad osalejaid osariigis Alabama.
Linnad osariigis Alabama
Ametlik uuringutekst (inglise keeles)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- University of Alabama, Birmingham
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06906640Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- University of Alabama, Birmingham
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06906627A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Heart Center Research, LLC, Huntsville
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Research Group, LLC, Anniston
- Eastern Shore Research Group, Fairhope
- Lakeview Clinical Research, Guntersville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Cahaba Research, Inc. - Trussville Location, Birmingham
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07754461A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Birmingham Clinical Research, Birmingham
- Cullman Clinical Trials, Cullman
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Fairhope
- Research Site, Huntsville
- Research Site, Mobile
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Birmingham
- AURORA-2 Clinical Site, Huntsville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Central Research Associates - Flourish - PPDS, Birmingham
- AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
- AES - DRS - Optimal Research Alabama - Huntsville, Huntsville
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 15. sept 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Lakeview Clinical Research, Guntersville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Apogee Clinical Research, LLC, Huntsville
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 11. sept 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Flourish Research, Birmingham
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 11. sept 2026 · NCT07668388Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
Värbamine
Vanused 18–89 · Kõik sood · Uuendatud 9. sept 2026 · NCT07032844A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Birmingham
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07662213AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Univ of Alabama Birmingham, Birmingham
- Eastern Shore Rsrch Inst, LLC, Fairhope
- Chambliss Clinical Trials, LLC, Montgomery
VärbamineFaas 3
Vanused 45 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Huntsville
- Research Site, Mobile
- Research Site, Sheffield
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Birmingham
- Research Site, Daphne
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662044CGM for Management of Type 2 Diabetes in Pregnancy
- University of Alabama at Birmingham, Birmingham
Värbamine
Vanused 18–50 · Naised · Uuendatud 29. juuni 2026 · NCT06628453Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Central Research Associates, LLC dba Flourish Research, Birmingham
VärbamineFaas 2
Vanused 18–70 · Kõik sood · Uuendatud 15. juuni 2026 · NCT07502508DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- University of Alabama at Birmingham, Birmingham
VärbamineVaatlusuuring
Vanused 8–15 · Kõik sood · Uuendatud 7. mai 2026 · NCT06525259FELLAShip to Better Health
- The Worship Center Cristian Church, Birmingham
Värbamine
Vanused 18 ja vanemad · Mehed · Uuendatud 22. jaan 2026 · NCT07220213A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Värbamine
Vanused 12–18 · Kõik sood · Uuendatud 8. dets 2025 · NCT06902077Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.